Tamtam Try Tamtam free
MedLife logo

MedLife account plan

largest private medical network

At a glance

MedLife is Romania's largest private healthcare provider, with clinics, 18 hospitals and labs, and FY2025 revenue of RON 3,173,518,743 (+16.9%).

MedLife (Med Life S.A., founded 1996, Bucharest) is the largest private healthcare provider in Romania, running clinics, hospitals, laboratories, pharmacies, dentistry and corporate prevention packages, plus operations in Hungary and the Republic of Moldova. It has served over 6.5 million unique patients and has over 930,000 active corporate subscriptions; 51% of 2025 revenue came from individuals, 15% from corporations and 34% from the National Health Insurance House (NHIH). FY2025 IFRS revenue was RON 3,173,518,743 (+16.9%) and pro-forma adjusted EBITDA RON 459,728,962, but the group posted a net loss of RON 3,850,654 on higher financing costs. It works with over 5,200 doctors and over 4,600 nurses and medical staff, is listed on the Bucharest Stock Exchange (ticker "M") and is controlled by the Marcu family.

Business units

Strategic priorities

Regional expansion
On 21 October 2026 MedLife set the direction of accelerating expansion across Central and Eastern Europe with priority on the Balkans, via acquisitions, greenfields or partnerships and a regional investment platform with an international financial institution.
Genomics and AI
Scale the Longevity100+ genetic testing program, add microbiome analysis, and accelerate AI in imaging and laboratories; a new app combining biometrics, lab results, imaging and genome data is opening to all users.
Profitability of recent projects
After an intensive investment cycle, the main 2026 priority is to maximise profitability of organic projects; the 2026 EBITDA budget is RON 512 million.
Deleveraging
Net debt to pro forma EBITDA was 3.85x at end-June 2026, with a target of around 3.5x by end-2026; new debt will be in local currency.
Small and medium acquisitions
M&A focuses on small and medium-sized deals in Romania and the region, including aesthetics, sports and wellness; Qualipat (75%) was bought in August 2026.

Latest results

In H1 2026 IFRS revenue was RON 1,738,986,990 against RON 1,573,957,005 in H1 2025, with pro-forma sales up almost 11% and organic growth of 9.5%. Pro forma EBITDA rose 14.5% to 259m RON, a 16.4% margin, and operating profit edged up 2.3% to RON 86,257,266. The net result was a loss of RON 34,689,177, as the RON's fall against the EUR raised FX losses on euro borrowings. Management says the group is on track with its budget and plans no price increases, with volume growth offsetting a slightly lower ticket.

Investments and deals

Capital increase and regional platform
MedLife is considering issuing new shares of up to 20% of share capital over up to 18 months, and a platform investing in healthcare, prevention and wellness companies over a four-year horizon, with first investments expected in the first half of next year.
Acquisitions 2025-2026
Routine Med (Tulcea), All Clinic (Republic of Moldova), Medstar (Cluj-Napoca, completed January 29, 2026) and 75% of Qualipat (pathology and molecular testing, August 2026).
New facilities
A Pitești hyperclinic (over EUR 3 million), the Panduri hyperclinic in Bucharest (over EUR 1 million), a fourth Arad clinic with a Longevity Center and a Neolife oncology center in Bacău.
Robotic surgery and capex
Over 2 million Euro invested in robotic surgery at Polisano Sibiu; the 2026 CAPEX budget is EUR 20 million excluding acquisitions.

Challenges and risks

Currency exposure on euro debt
Interest-bearing debt was RON 2,023,753,968 at June 30, 2026, mostly in EUR; the RON's fall cost RON 56 million in the Q2 2026 financial result.
Slowing consumer spending
Consumption in Romania has been falling since October 2025 after tax increases, pressuring discretionary services such as dentistry.
State contracts for new hospitals
Two new hospitals still await National Health Insurance House contracts; one is EBITDA positive, the other slightly negative.
Clinical staff
Recruitment and retention of staff, wage inflation for clinical staff and emigration of doctors are stated risks.
Acquisition integration
Due diligence and post-acquisition integration are named risks for a group that has integrated over 100 companies.

What leadership says

“We are no longer just talking about treatment, but about anticipation.”

Mihai Marcu, Chairman and CEO · Letter to shareholders, MedLife Group 2025 Annual Report

“We are not currently looking at any large deals”

Mihai Marcu, Chairman and CEO · H1 2026 results conference call, August 28, 2026

“We remain attentive to consolidation opportunities across the region and believe that MedLife's expertise represents a significant competitive advantage in this process.”

Mihai Marcu, Chairman and CEO · Press release on new growth instruments, 21 October 2026

“We don't currently see any sizeable transactions materializing in the near term”

Dorin Preda, Deputy CEO · Q1 2026 results conference call, May 29, 2026

Where a supplier can help

AI for imaging and laboratories
Tied to the genomics and AI priority: AI imaging, lab automation and data tools fit MedLife's plan to accelerate AI in imaging and laboratories.
Hospital margin improvement
Tied to maximising profitability of recent organic projects: procurement, consumables and operational efficiency offers address a group whose consumables rose 27.0% in 2025.
Treasury and FX advisory
Tied to the euro debt exposure and the deleveraging target: local-currency financing, hedging and capital-markets advice fit the FX rebalancing under way.
Integration of acquired clinics
Tied to regional expansion and integration risk: IT, HR and finance integration services support a group buying companies in Romania and the Balkans.
Clinical recruiting
Tied to the staff retention risk: recruiting and retention services for doctors and nurses address a stated pressure.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like MedLife?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about MedLife

What does MedLife do?

MedLife runs Romania's largest private healthcare network: clinics, hospitals, laboratories, pharmacies, dentistry and corporate prevention packages, plus facilities in Hungary and the Republic of Moldova.

What is MedLife's revenue?

FY2025 IFRS revenue was RON 3,173,518,743, up 16.9%. H1 2026 revenue was RON 1,738,986,990.

How many people work at MedLife?

MedLife works with over 5,200 doctors, over 4,600 nurses and medical staff and over 2,500 administrative staff, and cites over 12,000 employees and collaborators.

Who leads MedLife?

Mihai Marcu is Chairman and CEO; Dorin Preda is Deputy CEO and Alina Irinoiu-Titu CFO.

What is MedLife's strategy?

MedLife combines organic growth and acquisitions in Romania with expansion across Central and Eastern Europe, prioritising the Balkans, while developing genomics, AI and prevention.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)